Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Erik Thunnissen, Rafael Rosell
-
+
Session Moderator
10:45 - 10:45 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:45 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
MA02.01 - Session Introduction
10:45 - 10:46 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
MA02.02 - Session Introduction
10:46 - 10:47 | Presenter: Rafael Rosell
- Abstract
Loading... -
+
MA02.03 - The Evolution of Lung Neuroendocrine Tumors
10:47 - 10:52 | Presenter: Nicolas Alcala
- Abstract
Loading... -
+
MA02.04 - Molecular Drivers and Therapeutic Targets for Neuroendocrine Transformation in Lung Cancer
10:52 - 10:57 | Presenter: Triparna Sen
- Abstract
Loading... -
+
MA02.05 - Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations
10:57 - 11:02 | Presenter: Jie Huang
- Abstract
Loading... -
+
MA02.06 - Discussant
11:02 - 11:12 | Presenter: Yuko Minami
- Abstract
Loading... -
+
MA02.07 - Aurora A Kinase Inhibition with VIC-1911Potentiates KRASG12C Inhibitor and Overcomes Resistance to Sotorasib in Lung Cancer
11:12 - 11:17 | Presenter: Jong Woo Lee
- Abstract
Loading... -
+
MA02.08 - Trametinib Inhibition of MEK1 2 Upregulates PD-L1 Expression in KRAS-Mutant NSCLC Through ID1 Downregulation
11:17 - 11:22 | Presenter: Ander Puyalto
- Abstract
Loading... -
+
MA02.09 - Impact of Baseline Clinicopathologic and Genomic Features on Outcomes to KRAS G12C Inhibitors in Patients with NSCLC
11:22 - 11:27 | Presenter: Giuseppe Lamberti
- Abstract
Loading... -
+
MA02.10 - Discussant
11:27 - 11:37 | Presenter: Sally Lau
- Abstract
Loading... -
+
MA02.11 - Live Q&A
11:37 - 11:45
- Abstract
Loading...
-
+
MA12 - Pathology: Tumour Diagnostics
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Pathology
- Moderators:Aleks Ryska, Deepali Jain
-
+
MA12.07 - Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma With Lepidic Growth
11:12 - 11:17 | Presenter: Erik Thunnissen
- Abstract
Loading... -
+
MA12.08 - Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component
11:17 - 11:22 | Presenter: Federica Filipello
- Abstract
Loading...
